CJC-1295 Without DAC Lyophilized Peptide Powder

This product contains a synthetic 29-amino-acid analog of growth hormone-releasing hormone (GHRH) that does not incorporate the C-terminal drug-affinity-complex (DAC) modification found in long-acting CJC-1295 DAC. It is supplied solely for qualified laboratory research involving GHRH-related peptide chemistry, receptor pharmacology, ligand–receptor interactions, and associated molecular signaling pathways.

Appropriate research applications may include analytical characterization, peptide-binding and functional assays, structure–activity comparisons, cAMP-associated signaling studies, and investigation of GHRH-related pathways in suitable biochemical or cellular models. Experimental design and interpretation should account for the exact peptide sequence, counterion, concentration, assay system, and other study-specific conditions.

CJC-1295 without DAC is chemically distinct from CJC-1295 DAC and does not contain the albumin-binding DAC moiety. Findings generated with DAC-containing CJC-1295—including published pharmacokinetic, endocrine, and human-study results—should not automatically be attributed to this non-DAC material.

The lyophilized format is intended to facilitate controlled laboratory handling and preparation.

This independently supplied research material is not an FDA-approved drug product and is not represented as sterile, injectable, pharmaceutical grade, or suitable for administration.

For Research Use Only. Not for human or veterinary use. Not for compounding, administration, diagnostic, therapeutic, clinical, or household applications.